Published March 29, 2026 | Version v1
Book chapter Open

An Evaluation of Dr. Bandorwala Leprosy Hospital Kondhwa (Pune): A Gender-wise Temporal Assessment of Leprosy Disease

  • 1. PDEA's Annasaheb Waghire College Otur, Tal. – Junner, Dist.- Pune

Description

Present paper is an attempt study in a case study of Dr. Bandorwala Leprosy Hospital Kondhwa (Pune) the gender-wise temporal assessment of leprosy disease was investigated. Leprosy, often known as Hansen's disease, is caused by Mycobacterium leprosy. It is an infectious sickness that persists. It mostly affects the skin and peripheral nerves and can cause severe deformity and impairment if therapy is not received. Leprosy has been severely stigmatized throughout history and culture since it was first identified in antiquity. Leprosy is a bacterial disease that can be debilitating and persistent, and it is caused by Mycobacterium leprosy e. Cases of the illness have been reported in many countries, including India. Disease incidence is highest in the poorest part of the world. Migration from endemic to no endemic leprosy areas may cause the disease to resurface. To ascertain the quantity of leprosy cases in Pune. Every year, leprosy cases that occurred in Pune City between 2010 and 2021 were compiled and analyzed, allowing researchers to observe how the disease's cases changed over time.

Files

17. Ramesh Gopale.pdf

Files (449.6 kB)

Name Size Download all
md5:d31c3862020e392296ba7a5d7f7dd11f
449.6 kB Preview Download

Additional details

References

  • 1. Britton WJ, Lockwood DN. Leprosy. Lancet 2004; 363:1209-19. 2. Fine PE, 2008. Leprosy's global statistics still room for improvement. Lepr Rev 79: 235 – 238. 3. Fischer M. Leprosy - an overview of clinical features, diagnosis, and treatment. J Dtsch Dermatol Ges. 2017; 15:801–27. 4. Florida Department of Health. Hansen's disease (leprosy). FL Health CHARTS. 2019 5. Florida Department of Health. Reportable disease/conditions in Florida. 2021 [cited 2022 May 19]. https://www.floridahealth.gov/diseases-and-conditions/disease-reporting-and-management 6. https://www.who.int/news-room/fact-sheets/detail/leprosy 7. International Organization for Migration. World Migration Report 2020 https://publications.iom.int/system/files/pdf/wmr_2020.pdf 8. International Organization for Migration. World Migration Report 2020 [cited 2022 May 19]. 9. Jopling WH. Clinical aspects of leprosy. Tubercle 1982; 63:295-305. 10. Krishna, T.V. and S. Rama Krishna Geo-Spatial and Temporal Study of Leprosy Disease in Visakhapatnam District, Andhra Pradesh, India. International Journal Dental and Medical Sciences Research Volume 3, Issue 2, Mar-Apr 2021 pp 98-104 www.ijdmsrjournal.com ISSN: 2582-6018 11. Laskaris G. Lepra. En: Atlas de enfermedades orales. Barcelona: Masson; 2005. p. 196. 12. MILEP2 Study Group, 2000. Approaches to studying the transmission of Mycobacterium leprae. Lepr Rev 71 (Suppl): S26 – S29. 13. Moet FJ, Meima A, Oskam L, Richardus JH, 2004. Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions. Lepr Rev 75: 310 – 326. 14. Nolen L, Haberling D, Scollard D, Truman R, Rodriguez-Lainz A, Blum L, et al.; Centers for Disease Control and Prevention (CDC). Incidence of Hansen's disease—United States, 1994-2011. MMWR Morb Mortal Wkly Rep. 2014; 63:969–72.